AptaBio Therapeutics Inc
KOSDAQ:293780
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
STM Group PLC
LSE:STM
|
IM |
|
D
|
Daythree Digital Bhd
KLSE:DAY3
|
MY |
|
S
|
Sai Gon Cargo Service Corp
VN:SCS
|
VN |
|
H
|
Hitachi Transport System Ltd
TSE:9086
|
JP |
|
Herfy Food Services Company SJSC
SAU:6002
|
SA |
|
C
|
Chia Ta World Co Ltd
TWSE:2033
|
TW |
|
B
|
Bursa Cimento Fabrikasi AS
IST:BUCIM.E
|
TR |
|
Middle East Healthcare Company SJSC
SAU:4009
|
SA |
|
Fuji Soft Service Bureau Inc
TSE:6188
|
JP |
AptaBio Therapeutics Inc
Research & Development
AptaBio Therapeutics Inc
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
AptaBio Therapeutics Inc
KOSDAQ:293780
|
Research & Development
-₩12B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-39%
|
CAGR 10-Years
N/A
|
|
|
Celltrion Inc
KRX:068270
|
Research & Development
-₩208B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-14%
|
|
|
O
|
OliX Pharmaceuticals Inc
KOSDAQ:226950
|
Research & Development
-₩25.6B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
|
V
|
Voronoi Inc
KOSDAQ:310210
|
Research & Development
-₩17.9B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
Alteogen Inc
KOSDAQ:196170
|
Research & Development
-₩28.4B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-35%
|
CAGR 10-Years
-31%
|
|
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
Research & Development
-₩95.6B
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
N/A
|
|
AptaBio Therapeutics Inc
Glance View
Aptabio Therapeutics, Inc. operates as a pharmaceutical biotechnology company that develops intractable innovative drugs based on original platform technology. The company is headquartered in Yongin, Gyeonggi-Do and currently employs 28 full-time employees. The company went IPO on 2019-06-12. The firm is developing anti-cancer drugs, drugs for inflammatory and fibrotic diseases and diabetic complications drugs, among others.
See Also
What is AptaBio Therapeutics Inc's Research & Development?
Research & Development
-12B
KRW
Based on the financial report for Sep 30, 2025, AptaBio Therapeutics Inc's Research & Development amounts to -12B KRW.
What is AptaBio Therapeutics Inc's Research & Development growth rate?
Research & Development CAGR 5Y
-39%
Over the last year, the Research & Development growth was 14%.
